{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:21:50Z","timestamp":1789723310634,"version":"4.0.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Defective efferocytosis in ulcerative colitis (UC) exacerbates inflammation due to impaired clearance of apoptotic cells, yet the molecular mechanisms linking efferocytosis-related genes to therapeutic outcomes remain unclear. This study aims to investigate the role of efferocytosis in UC and the key regulatory mechanism of efferocytosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Multi-omics integration of single-cell and bulk transcriptomic data from human UC colonic mucosa identified efferocytosis-active cellular subpopulations. Machine learning algorithms screened hub genes, followed by molecular docking to assess interactions with UST. A mouse colitis model was used to verify the inflammatory damage of UC and the key genes that play the role in efferocytosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In UC, the \u201ceat me\u201d and \u201cdigest me\u201d signaling pathways are predominantly upregulated in myeloid cells, while the \u201cfind me\u201d signaling cascade shows marked activation in stromal cells. Macrophages characterized by the M2 polarization demonstrate enhanced phagocytic proficiency and are instrumental in the engulfment and clearance of apoptotic cells, thereby alleviating the inflammatory cascade in UC. Six hub genes (ANXA1, PANX1, ANXA5, CD93, SERPINE1, MFGE8) were associated with UC progression and correlated with clinical response to UST. Molecular docking analysis revealed strong binding affinities between these gene-encoded proteins and UST. Transcriptomic and proteomic analyses confirmed dysregulated expression of these hub genes in the colitis model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study reveals cellular heterogeneity at different stages of efferocytosis in UC, identifies efferocytosis-related genes as critical regulators of mucosal repair and predictors of UST efficacy. Findings emphasize targeting macrophage-driven efferocytosis to resolve inflammation, offering novel strategies for improving treatment outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1597528","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T13:19:09Z","timestamp":1758287949000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Multi-omics reveals efferocytosis-related hub genes as biomarkers for ustekinumab response in colitis"],"prefix":"10.3389","volume":"16","author":[{"given":"Jun-meng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-sha","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.996057","article-title":"Molecular regulation after mucosal injury and regeneration in ulcerative colitis","volume":"9","author":"Zheng","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI123374","article-title":"Fbxw7 increases CCL2\/7 in CX3CR1hi macrophages to promote intestinal inflammation","volume":"129","author":"He","year":"2019","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-024-02503-w","article-title":"Intestinal mucosal barrier repair and immune regulation with an AI-developed gut-restricted PHD inhibitor","author":"Fu","year":"2024","journal-title":"Nat Biotechnol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.754475","article-title":"Pro-resolving factors released by macrophages after efferocytosis promote mucosal wound healing in inflammatory bowel disease","volume":"12","author":"Martin-Rodriguez","year":"2021","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e17815","DOI":"10.15252\/emmm.202317815","article-title":"Enhancement of efferocytosis through biased FPR2 signaling attenuates intestinal inflammation","volume":"15","author":"Wu","year":"2023","journal-title":"EMBO Mol Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2024.2311548","article-title":"Enhancement of LC3-associated efferocytosis for the alleviation of intestinal inflammation","volume":"20","author":"Wu","year":"2024","journal-title":"Autophagy"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1804094115","article-title":"C-type lectin receptor LSECtin-mediated apoptotic cell clearance by macrophages directs intestinal repair in experimental colitis","volume":"115","author":"Yang","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2020.1741332","article-title":"PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation","volume":"17","author":"Wu","year":"2021","journal-title":"Autophagy"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00470-y","article-title":"Drugging the efferocytosis process: concepts and opportunities","volume":"21","author":"Mehrotra","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2021.02.025","article-title":"The ABCA1-efferocytosis axis: A new strategy to protect against atherosclerosis","volume":"518","author":"Chen","year":"2021","journal-title":"Clin Chim Acta"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-024-01255-8","article-title":"Integrating bulk RNA and single-cell sequencing data unveils efferocytosis patterns and ceRNA network in ischemic stroke","volume":"16","author":"Yuan","year":"2025","journal-title":"Transl Stroke Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1038\/s41467-023-40156-6","article-title":"Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease","volume":"14","author":"Garrido-Trigo","year":"2023","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e70767","DOI":"10.1096\/fj.202500146RR","article-title":"M2-like macrophages exhibit sialic acid-enhanced efferocytosis via the Siglec CD22","volume":"39","author":"Kukan","year":"2025","journal-title":"FASEB J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1016\/j.immuni.2023.10.017","article-title":"The landscape of immune dysregulation in Crohn\u2019s disease revealed through single-cell transcriptomic profiling in the ileum and colon","volume":"56","author":"Kong","year":"2023","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/ijms25010348","article-title":"Comprehensive analysis of PANoptosis-related gene signature of ulcerative colitis","volume":"25","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41536-024-00347-1","article-title":"MSCs mediate long-term efficacy in a Crohn\u2019s disease model by sustained anti-inflammatory macrophage programming via efferocytosis","volume":"9","author":"Dave","year":"2024","journal-title":"NPJ Regener Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2022.01.002","article-title":"Macrophage COX2 mediates efferocytosis, resolution reprogramming, and intestinal epithelial repair","volume":"13","author":"Meriwether","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e20195","DOI":"10.1016\/j.heliyon.2023.e20195","article-title":"Macrophages in ulcerative colitis: A perspective from bibliometric and visual analysis","volume":"9","author":"Ji","year":"2023","journal-title":"Heliyon"},{"key":"B21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2024.11.018","article-title":"Early-age efferocytosis directs macrophage arachidonic acid metabolism for tissue regeneration","volume":"58","author":"Lantz","year":"2025","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","first-page":"14333","DOI":"10.1038\/s41598-020-70353-y","article-title":"Single-cell RNA sequencing uncovers heterogenous transcriptional signatures in macrophages during efferocytosis","volume":"10","author":"Lantz","year":"2020","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-med-052919-120048","article-title":"New therapeutics for ulcerative colitis","volume":"72","author":"Hirten","year":"2021","journal-title":"Annu Rev Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1597528\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T13:19:16Z","timestamp":1758287956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1597528\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2025.1597528"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1597528","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"article-number":"1597528"}}